PET/contrast-enhanced CT in oncology: "to do, or not to do, that is the question"

Radiol Med. 2022 Sep;127(9):925-927. doi: 10.1007/s11547-022-01496-3. Epub 2022 Jul 30.

Authors

Michele Scialpi¹, Tullo Ostilio Moschini², Giuseppe De Filippis³

Affiliations

¹ Division of Diagnostic Imaging, Department of Medicine and Surgery, Santa Maria Della Misericordia Hospital, University of Perugia, S. Andrea delle Fratte, Perugia, Italy. michelescialpi1@gmail.com.
² Division of Diagnostic Imaging, Department of Medicine and Surgery, Santa Maria Della Misericordia Hospital, University of Perugia, S. Andrea delle Fratte, Perugia, Italy.
³ Medical Office, Santa Maria Della Misericordia Hospital, Perugia, Italy.

PMID: 35907156
DOI: 10.1007/s11547-022-01496-3

No abstract available

Publication types

Editorial

MeSH terms

Contrast Media
Fluorodeoxyglucose F18*
Humans
Medical Oncology
Positron-Emission Tomography*
Radiopharmaceuticals
Tomography, X-Ray Computed

Substances

Contrast Media
Radiopharmaceuticals
Fluorodeoxyglucose F18